Literature DB >> 23532099

Methamphetamine alters blood brain barrier protein expression in mice, facilitating central nervous system infection by neurotropic Cryptococcus neoformans.

Eliseo A Eugenin1, Jade M Greco, Susana Frases, Joshua D Nosanchuk, Luis R Martinez.   

Abstract

Methamphetamine (METH) is a drug of abuse that is a potent and highly addictive central nervous system (CNS) stimulant. The blood brain barrier (BBB) is a unique interface that in part functions to prevent microbial invasion of the CNS. The effects of METH on brain vasculature have not been studied extensively. We hypothesized that METH alters the BBB integrity, increasing susceptibility to CNS infection. Using a murine model of METH administration, we demonstrated that METH alters BBB integrity and modifies the expression of tight junction and adhesion molecules. Additionally, we showed that BBB disruption accelerates transmigration of the neurotropic fungus Cryptococcus neoformans into the brain parenchyma after systemic infection. Furthermore, METH-treated mice displayed increased mortality as compared to untreated animals. Our findings provide novel evidence of the impact of METH abuse on the integrity of the cells that comprise the BBB and protect the brain from infection.

Entities:  

Keywords:  Cryptococcus neoformans; blood brain barrier; methamphetamine

Mesh:

Substances:

Year:  2013        PMID: 23532099      PMCID: PMC3719895          DOI: 10.1093/infdis/jit117

Source DB:  PubMed          Journal:  J Infect Dis        ISSN: 0022-1899            Impact factor:   5.226


  26 in total

1.  Chemokine-dependent mechanisms of leukocyte trafficking across a model of the blood-brain barrier.

Authors:  E A Eugenin; Joan W Berman
Journal:  Methods       Date:  2003-04       Impact factor: 3.608

2.  Cyclic strain-mediated regulation of vascular endothelial occludin and ZO-1: influence on intercellular tight junction assembly and function.

Authors:  Nora T Collins; Philip M Cummins; Olga C Colgan; Gail Ferguson; Yvonne A Birney; Ronan P Murphy; Gerardene Meade; Paul A Cahill
Journal:  Arterioscler Thromb Vasc Biol       Date:  2005-11-03       Impact factor: 8.311

3.  Self-aggregation of Cryptococcus neoformans capsular glucuronoxylomannan is dependent on divalent cations.

Authors:  Leonardo Nimrichter; Susana Frases; Leonardo P Cinelli; Nathan B Viana; Antonio Nakouzi; Luiz R Travassos; Arturo Casadevall; Marcio L Rodrigues
Journal:  Eukaryot Cell       Date:  2007-06-15

4.  Cryptococcal yeast cells invade the central nervous system via transcellular penetration of the blood-brain barrier.

Authors:  Yun C Chang; Monique F Stins; Michael J McCaffery; Georgina F Miller; Dan R Pare; Tapen Dam; Maneesh Paul-Satyaseela; Kwang Sik Kim; Kyung J Kwon-Chung; Maneesh Paul-Satyasee
Journal:  Infect Immun       Date:  2004-09       Impact factor: 3.441

5.  Methamphetamine disrupts blood-brain barrier function by induction of oxidative stress in brain endothelial cells.

Authors:  Servio H Ramirez; Raghava Potula; Shongshan Fan; Tess Eidem; Anil Papugani; Nancy Reichenbach; Holly Dykstra; Babette B Weksler; Ignacio A Romero; Pierre O Couraud; Yuri Persidsky
Journal:  J Cereb Blood Flow Metab       Date:  2009-08-05       Impact factor: 6.200

6.  Methamphetamine causes microglial activation in the brains of human abusers.

Authors:  Yoshimoto Sekine; Yasuomi Ouchi; Genichi Sugihara; Nori Takei; Etsuji Yoshikawa; Kazuhiko Nakamura; Yasuhide Iwata; Kenji J Tsuchiya; Shiro Suda; Katsuaki Suzuki; Masayoshi Kawai; Kiyokazu Takebayashi; Shigeyuki Yamamoto; Hideo Matsuzaki; Takatoshi Ueki; Norio Mori; Mark S Gold; Jean L Cadet
Journal:  J Neurosci       Date:  2008-05-28       Impact factor: 6.167

7.  Methamphetamine enhances histoplasmosis by immunosuppression of the host.

Authors:  Luis R Martinez; Mircea Radu Mihu; Attila Gácser; Laura Santambrogio; Joshua D Nosanchuk
Journal:  J Infect Dis       Date:  2009-07-01       Impact factor: 5.226

8.  Additive deleterious effects of methamphetamine dependence and immunosuppression on neuropsychological functioning in HIV infection.

Authors:  Catherine L Carey; Steven Paul Woods; Julie D Rippeth; Raul Gonzalez; Robert K Heaton; Igor Grant
Journal:  AIDS Behav       Date:  2006-03

Review 9.  Progress in understanding basal ganglia dysfunction as a common target for methamphetamine abuse and HIV-1 neurodegeneration.

Authors:  Shaji Theodore; Wayne A Cass; Avindra Nath; William F Maragos
Journal:  Curr HIV Res       Date:  2007-05       Impact factor: 1.581

10.  Occludin as a possible determinant of tight junction permeability in endothelial cells.

Authors:  T Hirase; J M Staddon; M Saitou; Y Ando-Akatsuka; M Itoh; M Furuse; K Fujimoto; S Tsukita; L L Rubin
Journal:  J Cell Sci       Date:  1997-07       Impact factor: 5.285

View more
  23 in total

1.  Methamphetamine Impairs IgG1-Mediated Phagocytosis and Killing of Cryptococcus neoformans by J774.16 Macrophage- and NR-9640 Microglia-Like Cells.

Authors:  Lilit Aslanyan; Hiu H Lee; Vaibhav V Ekhar; Raddy L Ramos; Luis R Martinez
Journal:  Infect Immun       Date:  2019-01-24       Impact factor: 3.441

2.  Intracellular Haemophilus influenzae invades the brain: is zyxin a critical blood brain barrier component regulated by TNF-α?

Authors:  Dana N Parisi; Luis R Martinez
Journal:  Virulence       Date:  2014-08-15       Impact factor: 5.882

Review 3.  The impact of substance abuse on HIV-mediated neuropathogenesis in the current ART era.

Authors:  Vanessa Chilunda; Tina M Calderon; Pablo Martinez-Aguado; Joan W Berman
Journal:  Brain Res       Date:  2019-08-29       Impact factor: 3.252

Review 4.  Role of microglia in methamphetamine-induced neurotoxicity.

Authors:  Enquan Xu; Jianuo Liu; Han Liu; Xiaobei Wang; Huangui Xiong
Journal:  Int J Physiol Pathophysiol Pharmacol       Date:  2017-06-15

5.  Capsular specific IgM enhances complement-mediated phagocytosis and killing of Cryptococcus neoformans by methamphetamine-treated J774.16 macrophage-like cells.

Authors:  Lilit Aslanyan; Vaibhav V Ekhar; Carlos M DeLeon-Rodriguez; Luis R Martinez
Journal:  Int Immunopharmacol       Date:  2017-05-25       Impact factor: 4.932

6.  Acute exposure to methamphetamine alters TLR9-mediated cytokine expression in human macrophage.

Authors:  Ariel Burns; Pawel Ciborowski
Journal:  Immunobiology       Date:  2015-09-08       Impact factor: 3.144

7.  Molecular pathology of brain matrix metalloproteases, claudin5, and aquaporins in forensic autopsy cases with special regard to methamphetamine intoxication.

Authors:  Qi Wang; Takaki Ishikawa; Tomomi Michiue; Bao-Li Zhu; Da-Wei Guan; Hitoshi Maeda
Journal:  Int J Legal Med       Date:  2014-02-13       Impact factor: 2.686

8.  Effects of HIV-1 Tat and Methamphetamine on Blood-Brain Barrier Integrity and Function In Vitro.

Authors:  Sulay Patel; Crystal R Leibrand; Preetha Palasuberniam; Pierre-Olivier Couraud; Babette Weksler; Fay M Jahr; Joseph L McClay; Kurt F Hauser; MaryPeace McRae
Journal:  Antimicrob Agents Chemother       Date:  2017-11-22       Impact factor: 5.191

9.  Galectin-1 suppresses methamphetamine induced neuroinflammation in human brain microvascular endothelial cells: Neuroprotective role in maintaining blood brain barrier integrity.

Authors:  Neil U Parikh; R Aalinkeel; J L Reynolds; B B Nair; D E Sykes; M J Mammen; S A Schwartz; S D Mahajan
Journal:  Brain Res       Date:  2015-07-30       Impact factor: 3.252

10.  Methamphetamine alters the TLR4 signaling pathway, NF-κB activation, and pro-inflammatory cytokine production in LPS-challenged NR-9460 microglia-like cells.

Authors:  Ana M Vargas; Dormarie E Rivera-Rodriguez; Luis R Martinez
Journal:  Mol Immunol       Date:  2020-03-26       Impact factor: 4.407

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.